Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« The Brain Business -- Great Potential and Big Risks | Main | Jiaolu - Anxiety and Consumption in China »

July 12, 2005

New River and Ernest Gallo Team Up To Tackle Tolerance

Email This Entry

Posted by Zack Lynch

New River Pharmaceuticals (NRPH), a Neurotech Index 30 company, entered into a licensing agreement with the Ernest Gallo Clinic and Research Center at UCSF to investigate a new approach toward improving the use of opioid analgesics in the treatment of pain by reducing the development of tolerance.

According to a press release, preclinical work has suggested that doses of methadone administered with morphine at certain ratios could be used to increase analgesia and decrease the potential for opioid tolerance and dependence.

While opiates are extremely effective pain-killers, like all medications, they come with side effects, such as tolerance and in some cases addiction.

Under the agreement, New River will pay a licensing fee, potential milestones and royalty payments in exchange for an exclusive license to pursue the commercial development of the technology for the treatment of pain.

Comments (0) + TrackBacks (0) | Category: Public Neurotech News



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
NIO Unveils Top 10 Neuroscience Trends for 2009
NIO CEO Media Tour in NYC Gets Results
O Neurocaster
Manuscript Sent to Japan
2009 Stem Cell Trendsetters in Neurology and Psychiatry
Mental Health Parity Legislation Passes within Financial Package
Holy Neurofinancial Meltdown Bernanke
Interest in Neuropolicy Grows